Companies / Immucell Corp /De/
Immucell Corp /De/
Nasdaq: ICCCCIK 811641PORTLAND, ME
Financials · FY2025
Ownership
9.0M shares outstanding · as of May 1, 2026
Ownership
| Insiders | 2.27% | 205,700 |
| Institutions | 14.33% | 1,296,454 |
| Public float | 83.40% | 7,544,645 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Brigham Michael FDirector | 2.27% | 205,700 |
Brockmann Bobbi JoVP of Sales and Marketing · Director | — | — |
Fiori Timothy CChief Financial Officer · Director | — | — |
te Boekhorst Paul Francis OlivierCEOPresident and CEO · Director | — | — |
Tomsche David ScottDirector | — | — |
Institutional holders 28
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.86M | 3.35% | |
| $960.8K | 1.68% | |
| $831.9K | 1.50% | |
| $767.0K | 1.38% | |
| $624.8K | 1.12% | |
| $416.4K | 0.73% | |
| $349.1K | 0.63% | |
| $333.8K | 0.60% | |
| $243.7K | 0.44% | |
| $242.3K | 0.44% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Brigham Michael F Director | Exercise | Common Stock, par value $.01 per share | $146.0K | +25K +12.21% | 229,752 2.54% of shares | low |
| Mar 20, 2026 | Brigham Michael F Director | Other | Common Stock, par value $.01 per share | $146.0K | -24K -10.47% | 205,700 2.27% of shares | low |
| Apr 15, 2026 | Tomsche David Scott Director | Grant | Non Qualified Stock Options (Right to buy) | — | +12K | 11,933 0.13% of shares | low |
| Apr 16, 2025 | Tomsche David Scott Director | Grant | Non Qualified Stock Options (Right to buy) | — | +10K | 10,000 0.11% of shares | low |
| Jan 27, 2026 | te Boekhorst Paul Francis Olivier CEO | Grant | Stock Options (right to buy) | — | +110K | 110,000 1.22% of shares | low |
| Jan 27, 2026 | te Boekhorst Paul Francis Olivier CEO | Grant | Stock Options (right to buy) | — | +110K | 109,500 1.21% of shares | low |
| Jan 27, 2026 | Fiori Timothy C Executive | Grant | Stock Options (right to buy) | — | +120K | 120,000 1.33% of shares | low |
| Jan 27, 2026 | Brockmann Bobbi Jo Executive | Grant | Stock Options (right to buy) | — | +100K | 100,000 1.11% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ICCC | Common Stock | 452525306 |